KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Astrana Health (ASTH) EPS (Basic) (2016 - 2025)

Astrana Health (ASTH) has disclosed EPS (Basic) for 16 consecutive years, with $0.12 as the latest value for Q4 2025.

  • Quarterly EPS (Basic) rose 185.71% to $0.12 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $0.46 through Dec 2025, down 49.45% year-over-year, with the annual reading at $0.46 for FY2025, 49.45% down from the prior year.
  • EPS (Basic) hit $0.12 in Q4 2025 for Astrana Health, up from $0.01 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $0.77 in Q3 2021 to a low of -$0.14 in Q4 2024.
  • Historically, EPS (Basic) has averaged $0.26 across 5 years, with a median of $0.28 in 2021.
  • Biggest five-year swings in EPS (Basic): skyrocketed 425.0% in 2023 and later tumbled 153.85% in 2024.
  • Year by year, EPS (Basic) stood at $0.28 in 2021, then plummeted by 128.57% to -$0.08 in 2022, then surged by 425.0% to $0.26 in 2023, then crashed by 153.85% to -$0.14 in 2024, then skyrocketed by 185.71% to $0.12 in 2025.
  • Business Quant data shows EPS (Basic) for ASTH at $0.12 in Q4 2025, $0.01 in Q3 2025, and $0.19 in Q2 2025.